« Previous
Next »
Annals of Epidemiology
Volume 17, Issue 5,
Supplement
, Pages
S16-S23
, May 2007
Moderate Alcohol Use and Reduced Mortality Risk: Systematic Error in Prospective Studies and New Hypotheses
-
Significant associations of alcohol use with disease outcome. All diseases dominated by case-control studies (≥66%) of the studies evaluated. (From Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta
Significant associations of alcohol use with disease outcome. All diseases dominated by case-control studies (≥66%) of the studies evaluated. (From Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38:613–619.)
-
Significant associations of alcohol use with disease outcome. All diseases dominated by prospective studies (≥50%) of the studies evaluated. (From Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-Significant associations of alcohol use with disease outcome. All diseases dominated by prospective studies (≥50%) of the studies evaluated. (From Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38:613–619 [essential hypertension also evaluated but, in essence, only one study was included in the evaluation, insufficient for comparison in our study].)
☆ Disclosure: The majority of funding for research performed by Dr. Fillmore has been derived from the National Institutes of Health (NIAAA). She has received a minor amount of seed money from NordAN, a collection of Scandinavian groups interested in the control of the accessibility of alcohol, and a minor amount of money from the International Center for Alcohol Policies to support an in-house paper on the nature of contemporary alcohol-related research and has received travel expenses from the same group at an earlier time. She has consulted for NIAAA and for the World Health Organization (WHO, Geneva and Europe). Dr. Stockwell periodically conducts consulting work for WHO and Health Canada on alcohol and other drug research issues. He is in receipt of funding from the Centre for Addictions Research of British Columbia, the British Columbia Ministry of Health, WHO, and the Canadian Institutes for Health Research. He has previously received travel expenses from the International Center for Alcohol Policies but has not received personal fees or research funds from alcohol or tobacco manufacturers or from pharmaceutical companies. Dr. Chikritzhs has received all of her research funding from the National Drug Strategy Commonwealth, Department of Health and Aging, Australia, through competitive grants with no links to the alcohol beverage industry. She has performed minor consulting to the health department in Western Australia. Dr. Bostrom has received the majority of his funding from the NIAAA and has performed statistical consulting for pharmaceutical companies and other industries, none connected with the alcohol beverage industry. The majority of work performed by Dr. Kerr has been derived from the NIAAA.
PII: S1047-2797(07)00007-5
doi: 10.1016/j.annepidem.2007.01.005
© 2007 Elsevier Inc. All rights reserved.
« Previous
Next »
Annals of Epidemiology
Volume 17, Issue 5,
Supplement
, Pages
S16-S23
, May 2007
